Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies

by Andrea Teague, Kian-Huat Lim, Andrea Wang-Gillam
Published 2015-03-01

Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic Adenocarcinoma

by Eiichiro So, Zachary D. Crees, Danielle Crites, Andrea Wang-Gillam
Published 2017-08-01

389 Combining transcriptomic- and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumo...

by Laura Carter, Andrea Wang-Gillam, Johanna Bendell, Wungki Park, Wells Messersmith, Drew Rasco, Lei Zhou, Jean-Marie Bruey, Beatrice Ferguson, Jakob Dupont, Marya Chaney, Johann De Bono, David Nickle, Anna Galkin
Published 2020-11-01

Synergistic effects of concurrent blockade of PI3K and MEK pathways in pancreatic cancer preclinical models.

by Hua Zhong, Cesar Sanchez, Dirk Spitzer, Stacy Plambeck-Suess, Jesse Gibbs, Williams G Hawkins, David Denardo, Feng Gao, Robert A Pufahl, Albert C Lockhart, Mai Xu, David Linehan, Jason Weber, Andrea Wang-Gillam
Published 2013-01-01

Correction: Synergistic Effects of Concurrent Blockade of PI3K and MEK Pathways in Pancreatic Cancer Preclinical Models.

by Hua Zhong, Cesar Sanchez, Dirk Spitrzer, Stacy Plambeck-Suess, Jesse Gibbs, Williams G Hawkins, David Denardo, Feng Gao, Robert A Pufahl, Albert C Lockhart, Mai Xu, David Linehan, Jason Weber, Andrea Wang-Gillam
Published 2015-01-01

Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancers.

by Laura W Goff, Nilay Thakkar, Liping Du, Emily Chan, Benjamin R Tan, Dana B Cardin, Howard L McLeod, Jordan D Berlin, Barbara Zehnbauer, Chloe Fournier, Joel Picus, Andrea Wang-Gillam, Wooin Lee, A Craig Lockhart
Published 2014-01-01

Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation

by Comron Hassanzadeh, MD, MPH, Soumon Rudra, MD, Ani Bommireddy, BA, William G. Hawkins, MD, Andrea Wang-Gillam, MD, PhD, Ryan C. Fields, MD, Bin Cai, PhD, Justin Park, PhD, Olga Green, PhD, Michael Roach, MD, Lauren Henke, MD, Hyun Kim, MD
Published 2021-01-01

A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer

by Zishuo Ian Hu, Johanna C. Bendell, Andrea Bullock, Noelle K. LoConte, Hassan Hatoum, Paul Ritch, Hugo Hool, Joseph W. Leach, James Sanchez, Davendra P. S. Sohal, John Strickler, Ravindranath Patel, Andrea Wang‐Gillam, Irfan Firdaus, Kenneth H. Yu, Ann M. Kapoun, Eric Holmgren, Lei Zhou, Jakob Dupont, Vincent Picozzi, Vaibhav Sahai, Eileen M. O'Reilly
Published 2019-09-01

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment

by Hua Sun, Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl, Sherri R. Davies, Matthew H. Bailey, Tina M. Primeau, Jeremy Hoog, Jacqueline L. Mudd, Dennis A. Dean, Rajesh Patidar, Li Chen, Matthew A. Wyczalkowski, Reyka G. Jayasinghe, Fernanda Martins Rodrigues, Nadezhda V. Terekhanova, Yize Li, Kian-Huat Lim, Andrea Wang-Gillam, Brian A. Van Tine, Cynthia X. Ma, Rebecca Aft, Katherine C. Fuh, Julie K. Schwarz, Jose P. Zevallos, Sidharth V. Puram, John F. Dipersio, The NCI PDXNet Consortium, Brandi Davis-Dusenbery, Matthew J. Ellis, Michael T. Lewis, Michael A. Davies, Meenhard Herlyn, Bingliang Fang, Jack A. Roth, Alana L. Welm, Bryan E. Welm, Funda Meric-Bernstam, Feng Chen, Ryan C. Fields, Shunqiang Li, Ramaswamy Govindan, James H. Doroshow, Jeffrey A. Moscow, Yvonne A. Evrard, Jeffrey H. Chuang, Benjamin J. Raphael, Li Ding
Published 2021-08-01